Navigation Links
CMX001 Shows Antiviral Activity in Immunocompromised Transplant Patients With Severe Adenovirus Infection
Date:5/11/2011

rable plasma viremia at baseline, and had viral load data available at > 2 weeks after the first dose of CMX001.  The majority of CMX001 treated patients had a > 99 percent decrease in viral load compared to baseline after two weeks of therapy.  There was a median -2.5 log10 change in viremia from baseline by the last timepoint (range -6.0 to +0.3 log10).  Patients who had either sensitive virus or no proven resistance had a median decrease of almost 1000-fold (-2.9 log10) from baseline.  In patients with pre-existing resistance to CDV, attributable to prior suboptimal cidofovir (CDV) therapy, antiviral activity of CMX001 was a median -0.55 log10 decrease from baseline. Additionally, higher plasma exposure to CMX001 appeared to correlate with a more rapid response.  

These data were presented by Randall Lanier, PhD, Senior Director of Virology, Chimerix, at the 24th Annual International Conference on Antiviral Research in an oral presentation titled “CMX001 (Hexadecyloxypropyl Cidofovir) Antiviral Activity against Adenovirus in Patients Correlates with Drug Levels and Viral Sensitivity” (Abstract # 33).  

About Chimerix

Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health.

The company’s lead candidate, CMX001, is being developed as a potential broad spectrum antiviral agent for the treatment of life-threatening double-stranded DNA (dsDNA) viral diseases. Over 475 people have received CMX001 to date, with a growing body of evidence supporting the drug’s antiviral activity in humans.

Clinical studies of CMX001 include an ongoing Phase 2 study of the prevention/control of cytomegalovirus (CMV) in hematopoietic stem cell transplant patients (CMX001-201), a Phase 2 study being initiated for the treatment of adenovirus (AdV) infection in pe
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Disseminated Adenovirus Infection Eradicated in a Pediatric Hematopoietic Stem Cell Transplantation Recipient Who Received Chimerixs Lead Antiviral CMX001
2. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
3. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
4. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
5. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
6. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
7. New Device to Support Blood Circulation for Heart Patients Shows Improved Outcomes Compared to Current Treatment
8. Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure
9. Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis
10. Tissue Engineering Shows Promise to Revolutionize Transplant Medicine
11. Phase I Research of Extended-Release Topiramate Shows Less Fluctuation in Plasma Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015  Dr. Yair Walzer has ... vaginal health issues often caused by menopause. The MonaLisa Touch™, ... anesthesia, received FDA clearance in 2014. Dr. Walzer is one ... to offer the special fractional CO 2 laser specifically ... survivors. In 2010 there were greater than ...
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/hgs483/cardiovascular ) has ... "Cardiovascular Drug Delivery - Technologies, Markets and ... delivery to the cardiovascular system is different from ... and physiology of the vascular system; it supplies ... body. Drugs can be introduced into the vascular ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina , ... Research Network and Molecular Health have announced a collaboration ... diagnostic decision support to the majority of cancer patients ... Network will collaborate with Molecular Health to harness the ... identify cohorts from hundreds of thousands of patients to ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
(Date:5/30/2015)... 2015 On Sunday, June 14, 2015, ... – Jefferson Health will host Journey to Survivorship, a ... speaker, brunch and resources for cancer survivors and their ... the event will be Kathy LaTour, editor-at-large for Cure ... then again in 2007, LaTour provides a unique perspective ...
(Date:5/30/2015)... Hod-Hasharon, Israel and Montreal, Canada (PRWEB) May 30, 2015 ... inspection, print process control, and quality assurance, is joining ... offer advanced offline inspection solutions to the worldwide printing ... will provide AVT with a new software engine for ... the specific needs of the printing industry and its ...
(Date:5/30/2015)... May 30, 2015 Thousands of aesthetic ... Aesthetic Meeting, sponsored by the American Society for Aesthetic ... on hand was Zeltiq, the parent company of one ... CoolSculpting. With blazing growth, the one-of-a-kind device just ... , Zeltiq is currently in the news for gaining ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 One of ... lack of local healthcare options available. Often, the ruralness ... healthcare. For those in rural areas feeling the crunch ... health insurance or tired of paying high premiums and ... connecting patients with licensed physicians via the power of ...
(Date:5/30/2015)... Aliso Viejo, CA (PRWEB) May 30, 2015 ... variety of unique designs and animations. Instantly add an elegant ... production while choosing from a range of clean design layouts. ... , ProIntro Magnify is extremely easy to use. Simply ... make changes using the on-screen-controls and parameters in the Inspector ...
Breaking Medicine News(10 mins):Health News:Abington Hospital to Host Cancer Survivorship Event 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 3Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 3Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2
... have tripled in Idaho (central) and health officials are advising ... 72 cases have been // reported totally by ... Boise, Elmore (17) and Valley counties in southwest Idaho. Statistics ... when compared to the 10 year average period of 23 ...
... charge as he was suffering from Parasomnia, but the victim is ... case against him in Canadian Supreme court. Jan Luedecke was said ... they were both in a drunken state in the same sofa. ... could remember of the act. Parasomnia is a condition in which ...
... funded survey indicates that the ageing population in Kerala which ... a day and most are non-vegetarians. ,Almost ... in Kerala eat three meals a day, according to ‘Kerala ... some interesting problem with the health of the elderly population. ...
... research team comprising Scott Belcher, PhD, did a study ... 'at surprisingly low doses.' , ,Worded by Dr. ... show that oestrogen’s rapid signalling mechanisms are active in ... to be involved with sexual differences or reproductive functions,' ...
... of Alberta has revealed that different parts of the human ... same tasks. This goes to prove that the brains // ... volunteers for the study were called upon to perform simple ... while the functional Magnetic Resonance Imaging (fMRI) technology was used ...
... product like food cans, water pipes, dental sealants and milk ... research team guided by Scott Belcher, PhD, at the University ... December 2005 edition that even low level of Bisphenol A ... of the brain and is also concerned with disease and ...
Cached Medicine News:Health News:Three meals daily Keeps 'Kerala's elderly Healthy 2Health News:Food packaging with Bisphenol A damages the brain 2Health News:Bisphenol A In Food Containers Has Adverse Effect On Brain Tissue 2
... Intramedullary fixation has greatly enhanced ... fractures. The Biomet Low Profile ... in the treatment of unstable ... disease with pathologic or impending ...
Arthroscopic instrument system for instability and SLAP fixation....
Arthroscopic instrument system for instability and SLAP fixation....
Suture Cutter, Open Ended, Left Notch...
Medicine Products: